IMMT and cancer: As indicated by Fig. 7D, the significantly enriched pathways included dilated cardiomyopathy (5.52%), ECM-receptor interaction (6.63%), motor proteins (6.63%), protein processing in the endoplasmic reticulum (7.18%), microRNAs in cancer (6.63%), adrenergic signaling in cardiomyocytes (5.17%), focal adhesion (8.29%), PI3K-Akt signaling pathway (9.39%), MAPK signaling pathway (7.73%), and proteoglycans in cancer (6.63%).